• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags Cohance Lifesciences

Cohance Lifesciences News

Business

Suven Pharmaceuticals and Cohance Lifesciences Merge to Forge a Future-Ready CDMO Giant

Ryan Peterson 29 Mar, 2025

The National Company Law Tribunal has approved the merger of Suven Pharmaceuticals and Cohance Lifesciences, aiming to create a diversified CDMO platform focused on high-growth are...

Popular News

  • Economy

    UK Industrial Production Sees a Significant Rise of 0.9% in January, Signaling Economic Recovery

    14 Mar, 2025
  • Economy

    December Sees U.S. Manufacturing Sector Edge Towards Growth: ISM Report

    03 Jan, 2025
  • Economy

    France's Inflation Holds Steady at 1% in July: Energy Prices Dip While Food and Services Edge Up

    31 Jul, 2025
  • Business

    FILA Group Sells 5% DOMS Stake for Rs 798 Crore: A Strategic Move?

    20 Dec, 2024
  • Business

    American Express Unveils 'Programme Vasundhara' for Environmental Sustainability

    16 Dec, 2024
  • Business

    The Lingering Impact of HDFC Duo's Merger on Banking Sector's Credit Growth Dynamics

    21 Jul, 2025
  • Business

    Moscow Court Imposes Hefty Fine on TikTok for Data Access Violations

    27 Dec, 2024
  • Business

    Halliburton Faces a Slight Revenue Dip in Q4 2024, Yet Optimistic for Future Growth

    22 Jan, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.